- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06802627
Prehabilitation for Lung Cancer Patients Undergoing Lung Resection (Fit4LungNeo)
Influence of Prehabilitation on Postoperative Pulmonary Complications in Patient Undergoing Lung Resection Surgery
Lung surgical resection is the gold standard treatment for earlier stages of lung cancer patients. Nevertheless, postoperative pulmonary complications (PPC) are frequent, related to morbidity and mortality, increasing length of hospital stay (LOS), hospital costs, delaying adjuvant treatments, and patients suffering. The PPC often occurs on postoperative days, even after hospital discharge. Prehabilitation might reduce PPC, although few studies have compared the effectiveness of different training protocols, and no information is available regarding the possible benefits of expiratory muscle training. Moreover, there are no comparisons of the cost-benefits of other protocols in patients submitted to lung resection surgery.
This project investigates the effectiveness of and compares four different prehabilitation protocols in reducing PPC and LOS in patients selected for lung cancer resections.
Participants will be individuals referred to surgical resection due to lung cancer. Patients who meet the inclusion criteria will be invited to participate in the study. After clinical data collection, patients will be randomly allocated (simple method) into four groups [Control - CG, receiving an education session; Inspiratory muscle training group (IMT-G) receiving education session plus inspiratory muscle training (IMT); expiratory muscle training group (EMT-G) receiving education session plus expiratory muscle training (EMT); global exercise training group (GET-G) receiving education session plus a general exercise training (GET)], and evaluated for functional capacity (pulmonary function, respiratory muscle function, physical fitness, daily physical activity, dyspnoea, fatigue, quality of life, anxiety, depression, and a 24-hour food diary. Afterward, all patients will receive an education class and written information regarding healthy habits to follow before, during, and after hospital discharge. Patients allocated to exercise groups will start the prehabilitation intervention for two weeks. After the intervention, patient assessments will be repeated. After that, patients will be submitted to surgery, and anesthetic and surgical procedure data will be collected. During hospital recovery, all patients will receive physiotherapy and any etiological complications and the LOS will be recorded according to medical criteria. After hospital discharge, PPC will be monitored and recorded for 30 days; by then, patients will be submitted to the final assessment.
Study Overview
Status
Conditions
Detailed Description
To achieve the project's aim, sample size was calculated using G*Power 3.1.9.2, based on an effect size of 0.33 reported by Cavalheri & Granger (2017) in a study of preoperative exercise training and pulmonary complications after lung resection. With α = 0.05 and 95% power, a sample of 180 patients (45 per group) was determined. Accounting for a 10% dropout rate, the estimated total sample size is 200 patients.
The study was approved by the Ethical Committee from the Unidade Local de Saúde de São João (ULS São João), number (52/2024). All patients who meet the inclusion criteria, selected for pulmonary resections due to lung cancer, will be invited to participate in the study at the first preoperative appointment at the Cardiothoracic Department of the ULS São João. After signing the informed consent statement, a cod number will be attributed to the patients to protect his/her personal information. Participants will be randomized into one of the four groups: control group (CG), inspiratory muscle training group (IMT-G), expiratory muscle training group (EMT-G), and global exercise group (GET-G).
Assessments will be conducted at three time points: after obtaining written informed consent (baseline), after completing the prehabilitation program (post-intervention), and 30 days post-discharge (follow-up). Each assessment will take two days.
First day of assessments (data collection at the hospital):
A physician will carry one a medical assessment and collect data regarding anthropometric, sociodemographic, medical history, and behavioral risk factors. Following the medical assessment, a researcher will provide to the patients an accelerometer to measure daily physical activity. The accelerometers will be worn during waking hours until completing the prehabilitation program. Additionally, the researcher will collect data regarding patient-related outcome measures through questionaries (modified Medical Research Council Dyspnoea Questionnaire, International Physical Activity Questionnaire - Short Form, the Fatigue Assessment Scale, the Hospital Anxiety and Depression Scale, the EuroQol 5D-5L, food intake report from the day before (1-day recall)]. Only in the baseline assessment, it will be placing the evaluation of barriers for prehabilitation. The researcher will then schedule the second day of assessment within the next three or four days.
Second day (data collection at Faculty of Sport of the University of Porto):
In the second day, patients will be evaluated for pulmonary function, respiratory muscle function, and functional capacity and physical fitness. Pulmonary function and respiratory muscle function will provide information on respiratory dynamics, including the absolute and predicted values of forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), peak expiratory flow (PEF), Tiffeneau index (TI); total lung capacity (TLC), diffusion lung capacity for carbon monoxide (DLCO) and DLCO per unit alveolar volume (DLCO/VA). Regarding respiratory muscle function, maximal voluntary ventilation (MVV), maximal inspiratory pressure (MIP), and maximal expiratory pressure (MEP) will be measured. Thereafter, patients will be assessed for functional capacity / physical fitness [aerobic endurance (6-minute walk test); lower body strength (30-second sit to stand), agility, coordination and dynamic balance (time up and go), balance (3 balance positions), speed walk (4 meters), lower body power (5-time sit to stand), handgrip strength].
One week after the acceptance in participating in the study, the intervention program will start with an in-person education session for all patients, and those from the IMT-G, EMT-G and GET-G will thereafter start their 2-week training interventions at ULS São João. Detailed information of the training interventions is described in the Arms and Interventions section.
Following the intervention, all patients will be reassessed using the same procedures as at baseline, and then they will undergo the surgery. Information on ASA classification, ARISCAT score, minimum oxygen saturation, surgical approach, total surgical time, and extent of resection will be registered by the surgical team.
After surgery, all patients will receive standard care at the Cardiothoracic Department, including daily medical assessment, physiotherapy care, and analgesic protocol. Postoperative pulmonary complications (PPC) or from any other etiology, as well as the length of hospital stay (LOS), will be recorded. Any postoperative complication and hospital readmission in the next 30 days will be monitored and recorded. The criteria of PPC will be established according to the European Society of Thoracic Surgery and the Society of Thoracic Surgeons joint agreement and standardized definition (Fernandez et al., 2015).
Following hospital discharge, patients will be referred for outpatient physiotherapy and nursing care. Three weeks post-discharge, patients will have a medical appointment at the Cardiothoracic Department and scheduled for the post-discharge assessment. At this appointment, patients will receive an accelerometer to wear for one week, after which a follow-up assessment will be conducted. At the end of data collection, a cost effective analysis will be perfumed aiming to achieve the real economic cost-benefit of each protocol.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Filipa C Kendall, PhD
- Phone Number: 00351919840750
- Email: fckendall@fade.up.pt
Study Contact Backup
- Name: Lucimére Bonh, PhD
- Phone Number: 00351917028600
- Email: licimerebohn@fade.up.pt
Study Locations
-
-
-
Porto, Portugal, 4200-450
- Faculty of Sport - University of Porto
-
Contact:
- Filipa Kendall, Phd
- Phone Number: +351919840750
- Email: fckendall@fade.up.pt
-
Contact:
- Lucimére Bonh, PhD
- Phone Number: +351917028600
- Email: lucimerebonh@fade.up.pt
-
Contact:
- José F Oliveira, PhD
-
Contact:
- Débora G Silva, Masters
-
Contact:
- Luísa Gonçalves, PhD
-
Contact:
- Pedro Fernandes, MD
-
Contact:
- Ana Godinho, FT
-
Contact:
- Cristina Teixeira, Masters
-
Contact:
- Gabriela Fernandes, PhD
-
Contact:
- Ermelinda Eusébio
-
Contact:
- Lucimére Bohn, Phd
-
Contact:
- Filipa Kendall, Phd
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult patients accepted for lung resection surgery, due to lung cancer, at the Cardiothoracic Department of Unidade Local de Saúde São João
- Not included in any type of prehabilitation program
Exclusion Criteria:
- Diagnosis of cardiac, or hematological or neurologic diseases
- Pulmonary hypertension
- Renal failure
- Patients that underwent previous thoracic surgery
- Patients submitted to pneumectomy
- Patients with cognitive and mental disorders
- Patients with impairments in autonomous deambulation
- Patients already included in any prehabilitation program
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control Group (CG)
Control group will receive a single in-person preoperative education session at the Faculty of Sport of University of Porto, one week after the patient's inclusion in the study. The education session will be delivered for the patient and his/her caregiver or family member. The information that will be delivery is going to be focused on:
|
The information that will be delivery is going to be focused on:
|
|
Experimental: Inspiratory Muscle Training Group (IMT-G)
The IMT-G will be submitted to an education session (equal to the CG) plus 2-weeks of inspiratory muscle training (IMT). After the education session, patients will start the IMT program that will last two weeks. The IMT will be 5 days/ week, lasting ~20 minutes, using the PowerBreath KH2 device. All sessions will start with 5 min of stretching exercises and then the IMT. In the first week, the intensity of the PowerBreath KH2 will be set at 50% of the maximal inspiratory pressure (with 12 breaths per minute), and it will be increasing by 10% in the second week (with 15 breaths per minute). Patients will be continuously monitored by an oximeter and modified Borg scale All IMT session will take place at São João Hospital. |
The information that will be delivery is going to be focused on:
Education Session (described in the control group) Inspiratory muscle training (IMT) After the education session, patients will start the IMT program that will last two weeks. The IMT will be 5 days/ week, lasting 20 minutes, using the PowerBreath KH2 device. In the first week, the intensity of the PowerBreath KH2 will be set at 50% of the maximal inspiratory pressure (with 12 breaths per minute), and it will be increasing by 10% in the second week (with 15 breaths per minute). Patients will be continuously monitored by an oximeter and modified Borg scale |
|
Experimental: Expiratory Muscle Training Group (EMT-G)
The EMT-G will be submitted to an education session (equal to the CG) plus 2-weeks of expiratory muscle training (EMT). After the education session, patients will start the EMT that will last two weeks, 5 days a week. The sessions will last ~20 minutes and will be structured as follows:
|
The information that will be delivery is going to be focused on:
Education Session (described in the control group) Expiratory muscle training (EMT) After the education session, patients will start the EMT that will last two weeks, 5 days a week. The sessions will last 20 minutes and will be structured as follows: 4 minutes of total body stretching exercises 8 minutes of abdominal resistance exercises:
|
|
Experimental: Global Exercise Training Group (GET-G)
The GET-G will be submitted to an education session (equal to the CG) plus 2-weeks of physical exercise, 3 sessions per week, 45-60 minutes. The structure is: Warm-up 5 minutes of whole-body stretching exercises Main workout: -Aerobic: Week 1: 20 min of treadmill walking at 70% of the mean speed achieved on the 6-minute walk test and limited by 80% of the max theoretical heart rate. Week 2: 20 min of treadmill walking at 80% of the mean speed achieved on the 6-minute walk test and limited by 80% of the max theoretical heart rate. -Resistance Week 1: 8 exercises, 2 sets of 8-10 repetitions, using body weight and elastic bands. Week 2: 8 exercises, 2 sets of 10-12 repetitions, using body weight and elastic bands Coll-down: 5 min of whole-body stretching exercises, holding the point of feeling lightness discomfort for 15 seconds. Patients will be continuously monitored by an oximeter and modified Borg scale. |
The information that will be delivery is going to be focused on:
The GET-G will be submitted to an education session (equal to the CG) plus 2-weeks of physical exercise, 3 sessions per week, 45-60 minutes. The structure is: Warm-up: 5 minutes of whole-body stretching exercises Main workout: -Aerobic: Week 1: 20 min of treadmill walking at 70% of the mean speed achieved on the 6-minute walk test and limited by 80% of the max theoretical heart rate. Week 2: 20 min of treadmill walking at 80% of the mean speed achieved on the 6-minute walk test and limited by 80% of the max theoretical heart rate. -Resistance Week 1: 8 exercises, 2 sets of 8-10 repetitions, using body weight and elastic bands. Week 2: 8 exercises, 2 sets of 10-12 repetitions, using body weight and elastic bands Coll-down: 5 min of whole-body stretching exercises, holding the point of feeling lightness discomfort for 15 seconds. Patients will be continuously monitored by an oximeter and modified Borg scale. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Occurrence of postoperative pulmonary complications from surgery to 30 days after discharge
Time Frame: From the surgical procedure until 30 days after hospital discharge
|
PPC according to the European Society of Thoracic Surgery and the Society of Thoracic Surgeons (Fernandez et al., 2015):
|
From the surgical procedure until 30 days after hospital discharge
|
|
Length of hospital stay
Time Frame: From the surgical procedure until 30 days after hospital discharge
|
The number of days of postoperative hospitalization including hospital readmissions related to surgery, assessed in clinical data.
This will be based on the patients´ clinical files.
|
From the surgical procedure until 30 days after hospital discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in pulmonary function from baseline at the day before surgery and for 1 week 30 days after hospital discharge
Time Frame: Baseline, day before surgery and 30 days after hospital discharge
|
Absolute and relative values of Forced vital capacity (L) and (%); Forced Expiratory Volume in 1 second (L) and (%); Peak Expiratory Flow (L/s) and (%); Tiffeneau Index (%); Total Lung Capacity (L) and (%); Diffusion Lung Capacity for Carbon Monoxide (mmol/min/kPa) and (%); Diffusion Lung Capacity for Carbon Monoxide per unit alveolar volume (mmol/min/kPa/L) and (%) (MILLER et al., 2005).
These informations will be captured using the equipment Quark PFT®, Cosmed (Rome, Italy)
|
Baseline, day before surgery and 30 days after hospital discharge
|
|
Changes in respiratory muscle function from baseline at the day before surgery and for 1 week 30 days after hospital discharge
Time Frame: Baseline, day before surgery and 30 days after hospital discharge
|
Absolute and relative values of Maximal Voluntary Ventilation (L/min) and (%); Maximal Inspiratory Pressure (cmH2O) and (%); Maximal Expiratory Pressure (cmH2O) and (%) ("ATS/ERS Statement on respiratory muscle testing," 2002). These informations will be captured using the equipment Quark PFT®, Cosmed (Rome, Italy) Baseline, day before surgery and 30 days after hospital discharge |
Baseline, day before surgery and 30 days after hospital discharge
|
|
Changes in aerobic endurance from baseline, at the day before surgery and 30 days after hospital discharge
Time Frame: Baseline, day before surgery and 30 days after hospital discharge
|
Aerobic endurance will be assessed by the six-minute walk test (6-MWT), according to the American Thoracic Society (ATS) guidelines ("ATS statement: guidelines for the six-minute walk test," 2002).
Distance (in meters), maximum and minimum oxygen saturation (%) and maximum and minimum heart rate (bpm) will be recorded.
Both oxygen saturation and heart rates will be collected using the Spirodoc® (Rome, Italy).
|
Baseline, day before surgery and 30 days after hospital discharge
|
|
Changes in lower body strength from baseline, at the day before surgery and 30 days after hospital discharge
Time Frame: Baseline, day before surgery and 30 days after hospital discharge
|
To measure lower body strength, participants will be required to perform the sit-to-stand test of the Senior Fitness Test (JONES, RIKLI & BEAM, 1999).
Patients will be instructed to sit and stand the maximum times for 30 seconds.
The total number of repetitions will be recorded.
|
Baseline, day before surgery and 30 days after hospital discharge
|
|
Changes on handgrip strength from baseline, at the day before surgery and 30 days after hospital discharge
Time Frame: Baseline, day before surgery and 30 days after hospital discharge
|
Handgrip strength will be assessed using the dynamometer Jamar Plus + Digital hand dynamometer (Sammons Preston Inc., Bolingbrook, Illinois, USA).
Measurements will be carried out according to the American Society of Hand Therapists Recommendations (MacDermid et al., 2015).
In brief, three measurements will be assessed in both arms, with 1 minute interval between attempts.
The highest record for each arm will be used as the result.
|
Baseline, day before surgery and 30 days after hospital discharge
|
|
Changes in balance from baseline, at the day before surgery and 30 days after hospital discharge
Time Frame: Baseline, day before surgery and 30 days after hospital discharge
|
Balance will be measured by the balance test of the Short Physical Performance Battery.
In brief, participants must stand for the maximum of 10 seconds with the two feet side by side, holding semitandem, or holding tandem (GURALNIK et al., 1994).
|
Baseline, day before surgery and 30 days after hospital discharge
|
|
Changes in speed walk from baseline, at the day before surgery and 30 days after hospital discharge
Time Frame: Baseline, day before surgery and 30 days after hospital discharge.
|
Speed walk will be measured according to the Short Physical Performance Battery.
To measure speed walk, participants must walk along 4 meters using their usual speed.
Procedure will be performed 3 times (GURALNIK et al., 1994).
|
Baseline, day before surgery and 30 days after hospital discharge.
|
|
Changes in lower body power from baseline, at the day before surgery and 30 days after hospital discharge
Time Frame: Baseline, day before surgery and 30 days after hospital discharge.
|
Lower body power will be measured according to the Short Physical Performance Battery.
Participants will be asked to stand up and sit down from an armless chair 5 times as fast as possible, and the time spend in the task will be record, and to (GURALNIK et al., 2000).
|
Baseline, day before surgery and 30 days after hospital discharge.
|
|
Changes in agility, coordination and dynamic balance from baseline, at the day before surgery and 30 days after hospital discharge
Time Frame: Baseline, day before surgery and 30 days after hospital discharge.
|
Agility, coordination and dynamic balance will be measured by the time up and go test presented in the Vivifrail battery (IZQUIERDO et al., 2016).
The test will start with the participant sitting in a chair.
At the evaluated sign, the participants will stand up, walk 3 meters, and turn back to the chair.
The time to accomplish this task will be recorded.
|
Baseline, day before surgery and 30 days after hospital discharge.
|
|
Changes in dyspnea from baseline, at the day before surgery and 30 days after hospital discharge
Time Frame: Baseline, day before surgery and 30 days after hospital discharge
|
The modified Medical Research Council Dyspnea Questionnaire will be used to observed dyspnea.
The questionary contains 5 sentences about daily activities that might promote dyspnea, and the participants will classify their self-perception of dyspnea according to a score ranging from 0 to 4 points (RIBEIRO et al., 2022).
|
Baseline, day before surgery and 30 days after hospital discharge
|
|
Changes in fatigue from baseline, the day before surgery and 30 days after hospital discharge
Time Frame: Baseline, day before surgery and 30 days after hospital discharge
|
Fatigue will be determined through the Fatigue Assessment Scale, which is composed by 10 questions related to physical and mental fatigue, with a Lickert scale (1 to 5).
The total score ranges from 10 to 50, which higher results indicating a more severe fatigue profile (MICHIELSEN et al., 2004).
|
Baseline, day before surgery and 30 days after hospital discharge
|
|
Changes in anxiety and depression from baseline, the day before surgery and 30 days after hospital discharge
Time Frame: Baseline, day before surgery and 30 days after hospital discharge
|
Anxiety and depression will be evaluated with The Hospital Anxiety and Depression Scale.
This scale consists of two subscales, one for anxiety and the other for depression.
Higher results will indicate a potential presence of anxiety and depression (PAIS-RIBEIRO et al., 2007).
|
Baseline, day before surgery and 30 days after hospital discharge
|
|
Changes in quality of life from baseline, the day before surgery and 30 days after hospital discharge
Time Frame: Baseline, day before surgery and 30 days after hospital discharge
|
Health-related quality of life will be observed with the EuroQol 5D-5L.
This questionnaire contains the dimensions of mobility, self-care, usual activities, pain/discomfort and anxiety/depression, and participants also classified their perception of general health status (FENG et al., 2021).
|
Baseline, day before surgery and 30 days after hospital discharge
|
|
Changes in objectively daily physical activity from baseline at the day before surgery and for 1 week 30 days after hospital discharge
Time Frame: From baseline to the day before surgery and for 1 week 30 days after hospital discharge
|
Daily physical activity data will be objectively collected using GT3X+ accelerometers (ActiGraph®, LLC, Pensacola, FL, USA).
The devices will be wearing for 8 hours during the waiting time for surgery and during 7 days after 30 days of hospital discharge.
Data will be processed using the ActiLife software (ActiLife®, LLC, Pensacola, FL, USA).
|
From baseline to the day before surgery and for 1 week 30 days after hospital discharge
|
|
Changes in subjective daily physical activity from baseline, at the day before surgery and 30 days after hospital discharge
Time Frame: Baseline, day before surgery and 30 days after hospital discharge
|
The Physical Activity Questionnaire - Short Form (IPAQ-SF) will be used to report subjective daily physical activity.
Questions covering information about the weekly volume spent at vigorous, moderate and light physical activity, and the amount of time spending in the sitting position will be collected during the waiting time for surgery and during 7 days after 30 days of hospital discharge (CRAIG et al., 2003).
|
Baseline, day before surgery and 30 days after hospital discharge
|
|
Change from Baseline on body composition at the day before surgery and 30 days after hospital discharge
Time Frame: Baseline, day before surgery and 30 days after hospital discharge
|
Body composition variables (body mass (kg), fat-free mass (kg) and fat mass (kg)) will be analyzed with a bioimpedance (InBody 770®, InBody Co. Ltd., Seoul, South Korea).
|
Baseline, day before surgery and 30 days after hospital discharge
|
|
Changes in body mass index from baseline at the day before surgery and 30 days after hospital discharge
Time Frame: Baseline, day before surgery and 30 days after hospital discharge
|
Body mass index will be calculated by the formula: weight divided by squared height.
Weight will be assessed with the scale InBody 770 ®, InBody Co. Ltd., Seoul, South Korea) and height with a wall mounted stadiometer.
|
Baseline, day before surgery and 30 days after hospital discharge
|
|
Changes in food intake from baseline at the day before surgery and 30 days after hospital discharge
Time Frame: Baseline, day before surgery and 30 days after hospital discharge
|
Registration of food intake, including alcohol consumption, will be determined with the 1-day food record.
Data will be analyzed using the Food Processor Software®.
|
Baseline, day before surgery and 30 days after hospital discharge
|
|
Changes in tabaco smoking habits from baseline at the day before surgery and 30 days after hospital discharge
Time Frame: Baseline, day before surgery and 30 days after hospital discharge
|
Registration of smoking habits as "never smoker", "former smoker" or "smoker".
For the "former smoker" and "smoker", it will be calculated the tabaco consumption by the number of pack year unity using the formula: number of cigarettes per day / 20 X number of smoking years (BERNAARDS et al., 2001).
|
Baseline, day before surgery and 30 days after hospital discharge
|
|
Economic impact
Time Frame: Surgical procedure until 30 days after hospital discharge
|
Specific costs attributed to each intervention and comparison cost-effectiveness of each program.
|
Surgical procedure until 30 days after hospital discharge
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sociodemographic variables
Time Frame: Baseline
|
Age (years), academic level (primary, secondary, bachelor, master, PhD), civil status (married, separated, widow, single, others).
These will be assessed by interview.
|
Baseline
|
|
Medical history
Time Frame: Baseline
|
Diagnosed of diseases and number of medications will be assessed by one of the research members.
|
Baseline
|
|
Barriers questionnaire for prehabilitation
Time Frame: Baseline
|
Participation in a prehabilitation program might be difficult for the same patients due to many reasons, thus, to clarify barriers and in future develop solutions, all patients who fulfill inclusion criteria will be asked to answer the barriers questionnaire, even those who decline to participate in the clinical trial.
The questionnaire has 21 questions with 5 possible answers and the last one in open version.
|
Baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: José F Oliveira, PhD, Faculty of Sport - University of Porto
Publications and helpful links
General Publications
- Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56. doi: 10.1093/gerona/56.3.m146.
- Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005 Aug;26(2):319-38. doi: 10.1183/09031936.05.00034805. No abstract available.
- Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1381-95. doi: 10.1249/01.MSS.0000078924.61453.FB.
- Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS, Ostir GV, Studenski S, Berkman LF, Wallace RB. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci. 2000 Apr;55(4):M221-31. doi: 10.1093/gerona/55.4.m221.
- Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994 Mar;49(2):M85-94. doi: 10.1093/geronj/49.2.m85.
- Troiano RP, Berrigan D, Dodd KW, Masse LC, Tilert T, McDowell M. Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc. 2008 Jan;40(1):181-8. doi: 10.1249/mss.0b013e31815a51b3.
- Jones CJ, Rikli RE, Beam WC. A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport. 1999 Jun;70(2):113-9. doi: 10.1080/02701367.1999.10608028.
- Trost SG, McIver KL, Pate RR. Conducting accelerometer-based activity assessments in field-based research. Med Sci Sports Exerc. 2005 Nov;37(11 Suppl):S531-43. doi: 10.1249/01.mss.0000185657.86065.98.
- American Thoracic Society/European Respiratory Society. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002 Aug 15;166(4):518-624. doi: 10.1164/rccm.166.4.518. No abstract available.
- Pais-Ribeiro J, Silva I, Ferreira T, Martins A, Meneses R, Baltar M. Validation study of a Portuguese version of the Hospital Anxiety and Depression Scale. Psychol Health Med. 2007 Mar;12(2):225-35; quiz 235-7. doi: 10.1080/13548500500524088. English, Portuguese.
- Feng YS, Kohlmann T, Janssen MF, Buchholz I. Psychometric properties of the EQ-5D-5L: a systematic review of the literature. Qual Life Res. 2021 Mar;30(3):647-673. doi: 10.1007/s11136-020-02688-y. Epub 2020 Dec 7.
- ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7. doi: 10.1164/ajrccm.166.1.at1102. No abstract available. Erratum In: Am J Respir Crit Care Med. 2016 May 15;193(10):1185. doi: 10.1164/rccm.19310erratum.
- Cavalheri V, Granger C. Preoperative exercise training for patients with non-small cell lung cancer. Cochrane Database Syst Rev. 2017 Jun 7;6(6):CD012020. doi: 10.1002/14651858.CD012020.pub2.
- Fernandez FG, Falcoz PE, Kozower BD, Salati M, Wright CD, Brunelli A. The Society of Thoracic Surgeons and the European Society of Thoracic Surgeons general thoracic surgery databases: joint standardization of variable definitions and terminology. Ann Thorac Surg. 2015 Jan;99(1):368-76. doi: 10.1016/j.athoracsur.2014.05.104.
- Michielsen, H. J., De Vries, J., Van Heck, G. L., Van de Vijver, F. J. R., & Sijtsma, K. (2004). Examination of the Dimensionality of Fatigue: The Construction of the Fatigue Assessment Scale (FAS). European Journal of Psychological Assessment, 20(1), 39-48. https://doi.org/10.1027/1015-5759.20.1.39
- Izquierdo M, Casas-Herrero A, Zambom-Ferraresi F, Martínez-Velilla N, Alonso-Bouzón C, RodríguezMañas L. ViviFrail - A Practical Guide for Prescribing a Multi-Component Physical Training Program to prevent weakness and falls in People over 70. Multi-Component Physical Exercise Program Vivifrail, 2016. https://vivifrail.com/wp-content/uploads/2019/11/VIVIFRAIL-ENG-Interactivo.pdf
- Ribeiro S, Cardoso CS, Valerio M, Machado J, Costa J, Rodrigues C, Rebelo-Marques A. Confirmatory Evaluation of the Modified Medical Research Council Questionnaire for Assessment of Dyspnea in Patients with Chronic Obstructive Pulmonary Disease in Portugal. Acta Med Port. 2022 Feb 1;35(2):89-93. doi: 10.20344/amp.15208. Epub 2021 Apr 19.
- MacDermid J, Solomon G, Fedorczyk J, Valdes K. Clinical assessment recommendations 3rd edition: Impairment-based conditions. American Society of Hand Therapists; 2015. https://editions.mydigitalpublication.com/publication/?i=826932&p=2&view=issueViewer
- Bernaards CM, Twisk JW, Snel J, Van Mechelen W, Kemper HC. Is calculating pack-years retrospectively a valid method to estimate life-time tobacco smoking? A comparison between prospectively calculated pack-years and retrospectively calculated pack-years. Addiction. 2001 Nov;96(11):1653-61. doi: 10.1046/j.1360-0443.2001.9611165311.x.
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Ethics Committee CHUSJ 52/2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lung Cancer
-
M.D. Anderson Cancer CenterRecruitingStage III Lung Cancer AJCC v8 | Lung Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage... and other conditionsUnited States
-
The University of Hong KongBach Mai Hospital; Tam Anh TP. Ho Chi Minh General Hospital; Asian Pacific Society...Not yet recruitingLung Nodules | Lung Cancer Screening | Suspected Lung CancerHong Kong
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RecruitingStage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; MedWaves, IncRecruitingLung Cancer | Lung Cancer Stage I | Lung Cancer Stage II | Stage I Lung Cancer | Stage I - II Primary Lung Cancer | Stage II Lung CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingCaregiver | Stage III Lung Cancer AJCC v7 | Stage I Lung Cancer AJCC v7 | Stage II Lung Cancer AJCC v7 | Stage IB Lung Cancer AJCC v7 | Stage IA Lung Cancer AJCC v7 | Stage IIA Lung Cancer AJCC v7 | Stage IIB Lung Cancer AJCC v7 | Stage IIIA Lung Cancer AJCC v7 | Stage IIIB Lung Cancer AJCC v7United States
-
WindMIL TherapeuticsBristol-Myers SquibbTerminatedNSCLC | Lung Cancer | Lung Cancer Metastatic | Lung Cancer, Non-small Cell | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non Small Cell Lung Cancer MetastaticUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Genentech, Inc.Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung... and other conditionsUnited States
-
Emory UniversityNational Cancer Institute (NCI)TerminatedLung Non-Small Cell Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
-
University of California, San FranciscoMerck Sharp & Dohme LLCWithdrawnLung Non-Small Cell Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
Clinical Trials on Education session
-
Simon GregsonNational Institute of Mental Health (NIMH); University of Copenhagen; London... and other collaboratorsCompleted
-
Wake Forest University Health SciencesCompleted
-
Good Samaritan Hospital Medical Center, New YorkRecruiting
-
University of GlasgowCompletedExercise | Healthy Women | Physical Activities | Muscular StrengthUnited Kingdom
-
University of NebraskaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
National University of SingaporeNational University Polyclinics, Singapore; Islamic Religious Council of SingaporeCompleted
-
Nantes University HospitalTerminated
-
Abant Izzet Baysal UniversityCompleted
-
Ghurki Trust and Teaching HospitalCompletedDisk, Herniated | Minimally Invasive Surgical ProceduresPakistan
-
Universidad de BurgosFundación Instituto Valenciano de Oncología; Fundación Trinidad AlfonsoCompletedBreast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Stage IIIASpain